Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma

International Journal of Colorectal Disease

Volumn 27, Issue 6, 2012, Pages 737-749

  Lee, Wendy ^a   Nelson, Rebecca ^a   Akmal, Yasir ^a   Mailey, Brian ^a   McKenzie, Shaun ^b   Artinyan, Avo ^c   Ashing Giwa, Kimlin Tam ^a   Chen, Yi Jen ^a   Garcia Aguilar, Julio ^a   Kim, Joseph ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Disparities; Neoadjuvant; Radiation; Rectal cancer

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; ASIAN; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CAUCASIAN; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; ETHNIC DIFFERENCE; FEMALE; HISPANIC; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; RECTUM ANTERIOR RESECTION; RECTUM CARCINOMA; UNITED STATES;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CONTINENTAL POPULATION GROUPS; ETHNIC GROUPS; FEMALE; HEALTHCARE DISPARITIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; SOCIOECONOMIC FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864429371     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1378-2     Document Type: Article

References (32)

1. Sankaranarayanan J,Watanabe-Galloway S, Sun J, Qiu F, Boilesen E, Thorson A (2010) Age and rural residence effects on accessing colorectal cancer treatments: a registry study. Am J Manag Care 16:265-273
2. Roetzheim R, Pal N, Gonzalez E, Ferrante J, Van Durme D, Krischer J (2000) Effects of health insurance and race on colorectal cancer treatments and outcomes. Am J Public Health 90:1746-1754
3. Kim J, Artinyan A, Christopher S, Lee W, McKenzie S, Mailey B, Chen S, Bhatia S, Pigazzi A, Garcia-Aguilar J (2010) An interaction of race and ethnicity with socioeconomic status in rectal cancer outcomes. Ann Surg 253:647-654
4. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer (1990). JAMA 264:1444-1450
5. Improved survival with preoperative radiotherapy in resectable rectal cancer (1997) Swedish Rectal Cancer Trial. N Engl J Med 336:980-987
6. Kapitejin E, Marijnen C, Nagtegaal I, Putter H, Steup W, Wiggers T, Rutten H, Pahlman L, Glimelius B, van Krieken J, Leer J, van de Velde C, Group DCC (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638-646
7. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess C, Karstens J, Liersch T, Schmidberger H, Raab R, Group GRCS (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
8. Weiser M, Quah H-M, Shia J, Guillem J, Paty P, Temple L, Goodman K, Minsky B, Wong W (2009) Sphincter preservation in low rectal cancer is facilitated by preoperative chemoradiation and intersphincteric dissection. Ann Surg 249:236-242
9. Minsky B (1998) Sphincter preservation in rectal cancer: preoperative radiation therapy followed by low anterior resection with coloanal anastomosis. Semin Radiat Oncol 8:30-35 (Pubitemid 28098952)
10. Minsky B (1994) Preoperative combined modality treatment for rectal cancer. Oncol (Williston Park) 8:53-68
11. Baxter N, Rothenberger D, Morris A, Bullard K (2005) Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States. Dis Colon Rectum 48:9-15
12. Engstrom PF, Arnoletti JP, Benson AB 3rd, Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS, Enzinger PC, Fakih MG, Fleshman J Jr., Fuchs C, Grem JL, Kiel K, Knol JA, Leong LA, Lin E, Mulcahy MF, Rao S, Ryan DP, Saltz L, Shibata D, Skibber JM, Sofocleous C, Thomas J, Venook AP, Willett C, National Comprehensive Cancer Network (2009) NCCN clinical practice guidelines in oncology: rectal cancer. J Natl Compr Canc Netw 7(8):838-881
13. Cronin D, Harlan L, Potosky A, Clegg L, Stevens J, Mooney M (2006) Patterns of care for adjuvant therapy in a random populationbased sample of patients diagnosed with colorectal cancer. Am J Gastroenterol 101:2308-2318 (Pubitemid 44477559)
14. Suh W, Blackstock A, Herman J, Konski A, Mohiuddin M, Poggi M, Regine W, Cosman B, Saltz L, Johnstone P (2008) ACR Appropriateness Criteria on resectable rectal cancer: expert panel on radiation oncology-rectal/anal cancer. Int J Radiat Oncol Biol Phys 70:1427-1430 (Pubitemid 351417772)
15. Kalady M, de Campos-Lobato L, Stocchi L, Geisler D, Dietz D, Lavery I, Fazio V (2009) Predictive factors of pathologic complete response after neoadjuvant chemoradiation for rectal cancer. Ann Surg 250:582-589
16. Das P, Skibber J, Rodriguez-Bigas M, Feig B, Chang G, Wolff R, Eng C, Krishnan S, Janjan N, Crane C (2007) Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer. Cancer 109:1750-1755 (Pubitemid 46668536)
17. Janjan N, Crane C, Feig B, Cleary K, Dubrow R, Curley S, Vauthey J, Lynch P, Ellis L, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff P, Allen P, Brown T, Skibber J (2001) Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24:107-112 (Pubitemid 32323343)
18. Kim S, Hong Y, Kim D, Kim T, Kim J, Im S, Lee K, Yun T, Jeong S, Choi H, Lim S, Chang H, Jung K (2011) Preoperative chemoradiation with cetuximab, irinotecan, and capecitabine in patients with locally advanced resectable rectal cancer: a multicenter Phase II study. Int J Radiat Oncol Biol Phys 81:677-683. doi:10.1016/j. ijrobp.2010.06.035
19. Wiltshire K, Ward I, Swallow C, Oza A, Cummings B, Pond G, Catton P, Kim J, Ringash J, Wong C, Wong R, Siu L, Moore M, Brierley J (2006) Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys 64:709-716 (Pubitemid 43183564)
20. Carlomagno C, Pepe S, D'Armiento F, D'Armiento M, Cannella L, De Stefano A, CrispoA, Giordano M, De Placido S (2010) Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer. Oncology 78:369-375
21. Unger K, Romney D, Koc M, Moskaluk C, Friel C, Foley E, Rich T (2011) Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphorylase expression. Int J Radiat Oncol Biol Phys 80:1377-1382. doi:10.1016/j.ijrobp.2010.04.016
22. Gorey K, Luginaah I, Bartfay E, Fung K, Holowaty E, Wright F, Hamm C, Kanjeekal S (2011) Effects of socioeconomic status on colon cancer treatment accessibility and survival in Toronto, Ontario, and San Francisco, California, 1996-2006. Am J Public Health 101:112-119
23. Booth C, Li G, Zhang-Salomons J, Mackillop W (2010) The impact of socioeconomic status on stage of cancer at diagnosis and survival: a population-based study in Ontario, Canada. Cancer 116:4160-4167
24. Chou J, Row D, Gonen M, Liu Y, Schrag D, Weiser M (2010) Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: a population-based study. Cancer 116:2560-2570
25. Baxter N, Morris A, Rothenberger D, Tepper J (2005) Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Rad Oncol 61:426-431 (Pubitemid 40164437)
26. Prolongation of the disease-free interval in surgically treated rectal carcinoma. Gastrointestinal Tumor Study Group (1985). N Engl J Med 1985:1465-1472
27. Tveit K, Guldvog I, Hagen S, Trondsen E, Harbitz T, Nygaard K, Nilsen J, Wist E, Hannisdal E (1997) Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84:1130-1135 (Pubitemid 27359494)
28. Kaminsky-Forrett M, Conroy T, Luporsi E, Peiffert D, Lapeyre M, Boissel P, Guillemin F, Bev P (1998) Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer. Int J Radiat Oncol Biol Phys 42:935-941 (Pubitemid 29004132)
29. Rödel C, Grabenbauer G, Papadopoulos T, Hohenberger W, Schmoll H, Sauer R (2003) Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098-3104 (Pubitemid 46613485)
30. Rödel C,Martus P, Papdoupolos T, Füzesi L,KlimpfingerM, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R,Wittekind C (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688-8696 (Pubitemid 46211512)
31. Roh M, Colangelo L, O'Connell M, Yothers G, Deutsch M, Allegra C, Kahlenberg M, Baez-Diaz L, Ursiny C, Petrelli N, Wolmark N (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124-5130
32. Fisher B, Wolmark N, Rockette H, Redmond C, Deutsch M, Wickerham D, Fisher E, Caplan R, Jones J, Lerner H (1988) Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 80:21-29 (Pubitemid 18076565)